ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE0031442068
Stock Name / FundiShares Core S&P 500 UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300YDM1GFZR5B4U80
ETF TickerIDUS(USD) LSE
ETF TickerIDUS.LS(USD) CXE
ETF TickerIUSA.AS(EUR) CXE
ETF TickerIUSA.DE(EUR) CXE
ETF TickerIUSA.LS(GBX) CXE
ETF TickerIUSA.MI(EUR) CXE
ETF TickerIUSAz(USD) CXE
ETF TickerIUSA(EUR) ETF Plus
ETF TickerIDUS.L(GBP) LSE

Holdings detail for INCY

Stock NameIncyte Corporation
TickerINCY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45337C1027
LEI549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib
(RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update
Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY)
Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00
Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY)
Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC
Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY)
Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY)
Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC
Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY)
Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY)
State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY)
Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY)
Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY)
Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus
Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares Core S&P 500 UCITS ETF USD (Dist) INCY holdings

DateNumber of INCY Shares HeldBase Market Value of INCY SharesLocal Market Value of INCY SharesChange in INCY Shares HeldChange in INCY Base ValueCurrent Price per INCY Share HeldPrevious Price per INCY Share Held
2025-12-03 (Wednesday)55,974USD 5,681,361INCY holding increased by 3358USD 5,681,3610USD 3,358 USD 101.5 USD 101.44
2025-12-02 (Tuesday)55,974USD 5,678,003INCY holding decreased by -33584USD 5,678,0030USD -33,584 USD 101.44 USD 102.04
2025-12-01 (Monday)55,974INCY holding decreased by -22USD 5,711,587INCY holding decreased by -198791USD 5,711,587-22USD -198,791 USD 102.04 USD 105.55
2025-11-25 (Tuesday)55,996INCY holding decreased by -198USD 5,910,378INCY holding decreased by -59673USD 5,910,378-198USD -59,673 USD 105.55 USD 106.24
2025-11-24 (Monday)56,194USD 5,970,051INCY holding increased by 234891USD 5,970,0510USD 234,891 USD 106.24 USD 102.06
2025-11-21 (Friday)56,194INCY holding decreased by -22USD 5,735,160INCY holding increased by 14620USD 5,735,160-22USD 14,620 USD 102.06 USD 101.76
2025-11-20 (Thursday)56,216USD 5,720,540INCY holding increased by 24735USD 5,720,5400USD 24,735 USD 101.76 USD 101.32
2025-11-19 (Wednesday)56,216INCY holding decreased by -44USD 5,695,805INCY holding decreased by -149046USD 5,695,805-44USD -149,046 USD 101.32 USD 103.89
2025-11-18 (Tuesday)56,260INCY holding decreased by -66USD 5,844,851INCY holding decreased by -22628USD 5,844,851-66USD -22,628 USD 103.89 USD 104.17
2025-11-17 (Monday)56,326INCY holding decreased by -88USD 5,867,479INCY holding decreased by -79121USD 5,867,479-88USD -79,121 USD 104.17 USD 105.41
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE0031442068

Show aggregate share trades of INCY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-01SELL-22103.890101.470 101.712USD -2,238 71.99 Loss of -654 on sale
2025-11-25SELL-198107.605105.160 105.405USD -20,870 71.84 Loss of -6,646 on sale
2025-11-21SELL-22103.200101.400 101.580USD -2,235 71.55 Loss of -661 on sale
2025-11-19SELL-44104.660100.300 100.736USD -4,432 71.28 Loss of -1,296 on sale
2025-11-18SELL-66107.265103.790 104.137USD -6,873 71.13 Loss of -2,178 on sale
2025-11-17SELL-88105.970103.830 104.044USD -9,156 70.98 Loss of -2,910 on sale
2025-11-13SELL-176107.760105.030 105.303USD -18,533 70.82 Loss of -6,069 on sale
2025-11-11SELL-44108.670105.530 105.844USD -4,657 70.65 Loss of -1,549 on sale
2025-11-10SELL-132108.810104.070 104.544USD -13,800 70.49 Loss of -4,496 on sale
2025-11-06SELL-44106.430103.075 103.410USD -4,550 70.32 Loss of -1,456 on sale
2025-11-04SELL-88103.860100.020 100.404USD -8,836 70.17 Loss of -2,660 on sale
2025-10-22SELL-2288.06088.210 88.195USD -1,940 70.09 Loss of -398 on sale
2025-10-21SELL-4487.30087.480 87.462USD -3,848 70.01 Loss of -768 on sale
2025-10-16BUY2287.31092.860 92.305USD 2,031 69.93
2025-10-14SELL-6685.96086.160 86.140USD -5,685 69.76 Loss of -1,081 on sale
2025-10-13SELL-8884.73085.150 85.108USD -7,490 69.69 Loss of -1,357 on sale
2025-09-25BUY2281.66084.450 84.171USD 1,852 69.33
2025-09-24SELL-6684.16084.820 84.754USD -5,594 69.25 Loss of -1,023 on sale
2025-09-18BUY2286.00086.070 86.063USD 1,893 69.17
2025-09-17BUY2284.80085.980 85.862USD 1,889 69.09
2025-08-19SELL-4485.46085.690 85.667USD -3,769 68.76 Loss of -744 on sale
2025-08-15SELL-2286.92087.060 87.046USD -1,915 68.58 Loss of -406 on sale
2025-08-13SELL-11085.85086.020 86.003USD -9,460 68.49 Loss of -1,926 on sale
2025-08-12SELL-28681.61081.820 81.799USD -23,395 68.42 Loss of -3,825 on sale
2025-08-07SELL-33078.20078.250 78.245USD -25,821 68.37 Loss of -3,258 on sale
2025-08-05BUY2277.72078.500 78.422USD 1,725 68.27
2025-07-31BUY6674.89077.460 77.203USD 5,095 68.24
2025-07-28BUY2270.16070.930 70.853USD 1,559 68.13
2025-07-25SELL-4470.20070.820 70.758USD -3,113 68.12 Loss of -116 on sale
2025-07-18BUY2267.86069.430 69.273USD 1,524 68.10
2025-07-14SELL-2269.98070.040 70.034USD -1,541 68.08 Loss of -43 on sale
2025-07-08SELL-4467.67068.650 68.552USD -3,016 68.07 Loss of -21 on sale
2025-07-02BUY13268.17069.100 69.007USD 9,109 68.07
2025-06-24SELL-4469.01069.540 69.487USD -3,057 68.04 Loss of -63 on sale
2025-06-23SELL-2267.26068.780 68.628USD -1,510 68.05 Loss of -13 on sale
2025-06-20SELL-13268.46069.190 69.117USD -9,123 68.05 Loss of -141 on sale
2025-06-12SELL-6669.22069.540 69.508USD -4,588 68.03 Loss of -97 on sale
2025-06-06BUY2268.77068.980 68.959USD 1,517 68.00
2025-06-02SELL-6665.31065.970 65.904USD -4,350 68.03 Profit of 140 on sale
2025-05-29SELL-2266.04066.260 66.238USD -1,457 68.06 Profit of 40 on sale
2025-05-27BUY2265.35065.800 65.755USD 1,447 68.10
2025-05-23BUY2264.25064.570 64.538USD 1,420 68.16
2025-05-21SELL-6664.78065.460 65.392USD -4,316 68.21 Profit of 186 on sale
2025-05-15BUY8862.76062.990 62.967USD 5,541 68.33
2025-05-14SELL-13261.16062.500 62.366USD -8,232 68.39 Profit of 795 on sale
2025-05-13SELL-26460.81061.150 61.116USD -16,135 68.44 Profit of 1,934 on sale
2025-05-07SELL-6659.55060.070 60.018USD -3,961 68.70 Profit of 573 on sale
2025-05-02SELL-2262.53062.870 62.836USD -1,382 68.87 Profit of 133 on sale
2025-04-29SELL-6660.43060.720 60.691USD -4,006 69.04 Profit of 551 on sale
2025-04-24BUY2258.97059.050 59.042USD 1,299 69.28
2025-04-22BUY8857.38058.040 57.974USD 5,102 69.48
2025-04-16BUY2257.73058.780 58.675USD 1,291 69.88
2025-04-15BUY2258.46059.950 59.801USD 1,316 69.98
2025-04-11BUY4456.87057.070 57.050USD 2,510 70.19
2025-04-09BUY11058.86059.370 59.319USD 6,525 70.42
2025-04-08BUY33056.97061.470 61.020USD 20,137 70.54
2025-04-07SELL-15460.29061.060 60.983USD -9,391 70.63 Profit of 1,486 on sale
2025-04-04SELL-33060.58063.570 63.271USD -20,879 70.73 Profit of 2,460 on sale
2025-04-02SELL-6662.33062.530 62.510USD -4,126 70.80 Profit of 547 on sale
2025-04-01SELL-2260.91062.000 61.891USD -1,362 70.90 Profit of 198 on sale
2025-03-31SELL-4460.55060.810 60.784USD -2,674 70.99 Profit of 449 on sale
2025-03-28BUY4460.60060.970 60.933USD 2,681 71.09
2025-03-25BUY6662.08063.270 63.151USD 4,168 71.38
2025-03-24BUY8862.78063.310 63.257USD 5,567 71.47
2025-03-21SELL-4461.92062.330 62.289USD -2,741 71.56 Profit of 408 on sale
2025-03-20BUY4460.58061.750 61.633USD 2,712 71.67
2025-03-19BUY8860.34061.150 61.069USD 5,374 71.79
2025-03-17SELL-6662.01063.450 63.306USD -4,178 72.01 Profit of 575 on sale
2025-03-14SELL-4467.86068.120 68.094USD -2,996 72.06 Profit of 174 on sale
2025-03-13SELL-13267.71068.970 68.844USD -9,087 72.10 Profit of 430 on sale
2025-03-11SELL-15468.07071.650 71.292USD -10,979 72.19 Profit of 139 on sale
2025-03-10SELL-8871.13071.890 71.814USD -6,320 72.21 Profit of 34 on sale
2025-03-06SELL-8870.09070.980 70.891USD -6,238 72.25 Profit of 119 on sale
2025-03-05SELL-13269.81069.970 69.954USD -9,234 72.27 Profit of 306 on sale
2025-03-04SELL-17669.68070.000 69.968USD -12,314 72.30 Profit of 411 on sale
2025-02-28SELL-11073.50073.630 73.617USD -8,098 72.31 Loss of -143 on sale
2025-02-26BUY4474.30075.310 75.209USD 3,309 72.28
2025-02-24BUY4474.01074.360 74.325USD 3,270 72.23
2025-02-21BUY2272.11072.970 72.884USD 1,603 72.23
2025-02-20SELL-6671.38071.520 71.506USD -4,719 72.24 Profit of 49 on sale
2025-02-14SELL-2270.42071.800 71.662USD -1,577 72.33 Profit of 15 on sale
2025-02-13SELL-28670.01072.690 72.422USD -20,713 72.36 Loss of -17 on sale
2025-02-12SELL-2269.05069.100 69.095USD -1,520 72.41 Profit of 73 on sale
2025-02-06SELL-8874.95075.490 75.436USD -6,638 72.49 Loss of -259 on sale
2025-02-05BUY2275.26075.740 75.692USD 1,665 72.45
2025-02-04BUY15474.12074.920 74.840USD 11,525 72.43
2025-01-29SELL-15473.72074.110 74.071USD -11,407 72.34 Loss of -267 on sale
2025-01-28BUY4473.15073.990 73.906USD 3,252 72.33
2025-01-24BUY2272.59073.680 73.571USD 1,619 72.32
2025-01-22BUY4472.41073.550 73.436USD 3,231 72.31
2025-01-16BUY4472.47072.980 72.929USD 3,209 72.30
2025-01-15BUY2272.46073.830 73.693USD 1,621 72.30
2025-01-10BUY4470.54072.600 72.394USD 3,185 72.34
2025-01-02BUY6669.53070.270 70.196USD 4,633 72.37
2024-12-31BUY4469.07069.200 69.187USD 3,044 72.44
2024-12-27BUY2269.23069.900 69.833USD 1,536 72.60
2024-12-20BUY6668.84069.110 69.083USD 4,559 72.91
2024-12-19BUY2267.06068.640 68.482USD 1,507 73.06
2024-12-18SELL-2267.55069.630 69.422USD -1,527 73.20 Profit of 83 on sale
2024-12-17BUY4469.40069.740 69.706USD 3,067 73.30
2024-12-13BUY2268.55070.790 70.566USD 1,552 73.54
2024-12-10BUY2272.48073.100 73.038USD 1,607 73.60
2024-12-06SELL-4475.92076.460 76.406USD -3,362 73.58 Loss of -124 on sale
2024-12-05BUY2274.92075.370 75.325USD 1,657 73.53
2024-12-04SELL-17674.62075.320 75.250USD -13,244 73.50 Loss of -309 on sale
2024-12-03BUY6672.03072.960 72.867USD 4,809 73.55
2024-12-02BUY11073.24074.700 74.554USD 8,201 73.56
2024-11-27BUY2275.45076.140 76.071USD 1,674 73.36
2024-11-26BUY15474.80074.950 74.935USD 11,540 73.30
2024-11-21BUY6670.39071.400 71.299USD 4,706 73.51
2024-11-20BUY4471.05071.680 71.617USD 3,151 73.64
2024-11-19BUY2270.56074.100 73.746USD 1,622 73.81
2024-11-18BUY4476.97077.010 77.006USD 3,388 73.62
2024-11-12BUY8880.58082.020 81.876USD 7,205 73.19
2024-11-11BUY4481.53083.540 83.339USD 3,667 72.63
2024-11-08BUY17683.38083.950 83.893USD 14,765 71.87
2024-11-07BUY15482.34082.970 82.907USD 12,768 71.06
2024-11-06BUY17680.95082.190 82.066USD 14,444 70.24
2024-11-05SELL-4477.28077.370 77.361USD -3,404 69.60 Loss of -342 on sale
2024-11-04BUY4475.75076.570 76.488USD 3,365 68.98
2024-11-01BUY15476.13076.330 76.310USD 11,752 68.19
2024-10-28BUY11065.69065.880 65.861USD 7,245 65.27
2024-10-25BUY24265.07065.740 65.673USD 15,893 65.32
2024-10-23SELL-2265.17066.100 66.007USD -1,452 65.43 Loss of -13 on sale
2024-10-21BUY2265.27066.550 66.422USD 1,461 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19321,923395451,11071.4%
2025-09-18244,9471,423469,74752.1%
2025-09-17277,858779546,95350.8%
2025-09-16359,781946576,37962.4%
2025-09-15347,4534582,22859.7%
2025-09-12353,0400631,53455.9%
2025-09-11448,7333,894739,70160.7%
2025-09-10490,727248671,93273.0%
2025-09-09515,3951,822682,79175.5%
2025-09-08308,184119479,82864.2%
2025-09-05256,7192,505512,04950.1%
2025-09-04422,6241,507834,71750.6%
2025-09-03381,6797,777624,92261.1%
2025-09-02547,12015,396816,26767.0%
2025-08-29148,294262304,42748.7%
2025-08-28164,0080347,48047.2%
2025-08-27248,926453513,40148.5%
2025-08-26365,1306709,32051.5%
2025-08-25478,1301,306642,31974.4%
2025-08-22344,3522,023596,30157.7%
2025-08-21198,7294,881335,30159.3%
2025-08-20351,6993,977555,34563.3%
2025-08-19343,1103,146574,32859.7%
2025-08-18366,1244,996653,10356.1%
2025-08-15480,8858,035625,79776.8%
2025-08-14593,55436,654806,06873.6%
2025-08-13845,18198,1601,257,50367.2%
2025-08-12462,89642,208678,68968.2%
2025-08-11385,211696595,89264.6%
2025-08-08248,925738426,18758.4%
2025-08-07268,864929420,48663.9%
2025-08-06554,642891731,48475.8%
2025-08-05361,6872,092623,87958.0%
2025-08-04338,0051,464519,15065.1%
2025-08-01414,814828572,87972.4%
2025-07-31570,8456,148777,41773.4%
2025-07-30471,30314,166881,19453.5%
2025-07-29966,64010,5811,593,70160.7%
2025-07-28382,23662625,51061.1%
2025-07-25216,96749422,99051.3%
2025-07-24348,27623528,51765.9%
2025-07-23297,903583487,29761.1%
2025-07-22267,987172446,48960.0%
2025-07-21223,626380406,72955.0%
2025-07-18241,218108471,58951.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy